The Short-Form Chronic Respiratory Disease Questionnaire was a Valid, Reliable, and Responsive Quality-of-Life Instrument in Acute Exacerbations of Chronic Obstructive Pulmonary Disease

2008 ◽  
Vol 61 (5) ◽  
pp. 489-497 ◽  
Author(s):  
Chu-Lin Tsai ◽  
Richard V. Hodder ◽  
John H. Page ◽  
Rita K. Cydulka ◽  
Brian H. Rowe ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Short Form ◽  
Chronic Respiratory Disease ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Life Instrument ◽  
Chronic Respiratory Disease Questionnaire ◽  
Acute Exacerbations ◽  
Disease Questionnaire

Pulmonary rehabilitation

2003 ◽  
Vol 13 (3) ◽  
pp. 175-182 ◽  
Author(s):  
Dipankar Dutta ◽  
Richard JA Butland ◽  
Ruma R Dutta ◽  
Miriam C Casey
Keyword(s):  
Quality Of Life ◽  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Rehabilitation ◽  
Exercise Programme ◽  
Chronic Respiratory Disease ◽  
Chronic Obstructive ◽  
Obstructive Pulmonary Disease ◽  
Multidisciplinary Education ◽  
Programme Of Care

Pulmonary rehabilitation is a multidisciplinary education and exercise programme of care for patients with chronic respiratory disease, particularly Chronic Obstructive Pulmonary Disease (COPD). It aims to reduce symptoms, decrease disability, increase participation in physical and social activities and improve overall quality of life in patients who may still be very disabled despite optimal pharmacological treatment. Pulmonary rehabilitation first began more than 30 years ago and is now established as an important part of the management of COPD.

Management of Chronic Obstructive Pulmonary Disease: A Review

2001 ◽  
Vol 14 (2) ◽  
pp. 126-142 ◽  
Author(s):  
Marie-France Beauchesne
Keyword(s):  
Quality Of Life ◽  
Chronic Obstructive Pulmonary Disease ◽  
Pulmonary Disease ◽  
The United States ◽  
Treatment Modalities ◽  
Chronic Obstructive ◽  
Duration Of Action ◽  
Obstructive Pulmonary Disease ◽  
Acute Exacerbations

Chronic obstructive pulmonary disease (COPD) affects about 14 million persons in the United States and is the only common cause of death that is increasing in incidence. Chronic management of this disorder includes nonpharmacologic interventions such as smoking cessation, immunization, nutritional support, and pulmonary rehabilitation. The pharmacotherapy of COPD is based on regular administration of bronchodilators, when symptoms are persistent. Long-acting bronchodilators have been shown to improve quality of life in patients with COPD. Ipratropium remains the anticholinergic of choice, but more specific agents with a longer duration of action should become available. Four recent large clinical trials on the use of inhaled corticosteroids (ICS) have been published. The results demonstrate that ICS do not alter the decline in lung function in patients with COPD. Patients with more severe COPD and frequent exacerbations may have a better quality of life and a reduced rate of exacerbations with ICS. Management of acute exacerbations involves three major pharmacologic treatment modalities: antibiotics, short-acting bronchodilators, and systemic steroids. Recent data shows the benefits of systemic corticosteroids in the management of acute exacerbations.

scholarly journals Validación del puntaje de valoración de la gravedad de la enfermedad pulmonar obstructiva crónica en población colombiana en un servicio de atención primaria

Biomédica ◽  
2020 ◽  
Vol 40 (4) ◽  
pp. 664-672
Author(s):  
Jorge Mario Estrada-Álvarez ◽  
Juan Pablo Orozco-Hernández ◽  
Luis Evelio Aristizábal-Franco
Keyword(s):  
Chronic Obstructive Pulmonary Disease ◽  
Severity Score ◽  
Chronic Respiratory Disease ◽  
Forced Expiratory Volume ◽  
Chronic Obstructive ◽  
Disease Severity Score ◽  
Obstructive Pulmonary Disease ◽  
Chronic Respiratory Disease Questionnaire ◽  
Enfermedad Pulmonar Obstructiva Crónica ◽  
Disease Questionnaire

Introducción. La enfermedad pulmonar obstructiva crónica (EPOC) es un importante problema de salud mundial con una alta morbimortalidad. Se requiere la medición de la gravedad de la enfermedad mediante una herramienta de fácil aplicación, bajo costo y fácil disponibilidad en áreas rurales.Objetivo. Evaluar la validez y confiabilidad del puntaje de valoración de la gravedad de la EPOC (Chronic Obstructive Pulmonary Disease Severity Score, COPDSS) en una población de atención primaria en Colombia.Materiales y métodos. Se hizo un estudio de corte transversal en una muestra de 100 pacientes con diagnóstico de EPOC según las guías GOLD. La validez concurrente se evaluó correlacionando los resultados del COPDSS con otras variables de importancia como las del cuestionario sobre la enfermedad respiratoria crónica (Chronic Respiratory Disease Questionnaire, CRQ) y el volumen espiratorio forzado en el primer segundo (Forced Expiratory Volume in one second, FEV1).Resultados. El COPDSS presentó una correlación significativa con el FEV1 (r=-0,33), con el CRQ (r=-0,57) y sus dimensiones: disnea (r=0,51), fatiga (r=0,53), función emocional (r=0,43) y control de la enfermedad (r=0,50). En el análisis factorial se determinó un solo factor con una varianza acumulada de 59,1 %. El análisis de coherencia interna mostró un alfa de Cronbach de 0,76, valor este considerado adecuado.Conclusiones. Se observó que el uso del COPDSS como cuestionario de valoración de la gravedad de pacientes con EPOC en Colombia tenía validez y confiabilidad adecuadas y que es de fácil aplicación en la atención primaria.

scholarly journals Case Report: Ninjin'yoeito May Improve Quality of Life After Hospitalization for Acute Illness in Patients With Frailty

2021 ◽  
Vol 8 ◽  
Author(s):  
Masayuki Kashima
Keyword(s):  
Quality Of Life ◽  
Short Form ◽  
Acute Illness ◽  
Chronic Obstructive ◽  
Total Quality ◽  
Obstructive Pulmonary Disease ◽  
Frail Patients ◽  
Traditional Japanese Medicine ◽  
Sf 36

Introduction: Frail patients are susceptible to a large number of diseases, and frailty particularly is known to develop after acute illness. No conventional drugs are known to prevent such exacerbation after acute illness. However, traditional Japanese medicine, Kampo, is thought to confer efficacious energy and nutritional supplements and serve to improve malaise after acute illness. Ninjin'yoeito is a representative Kampo medicine for such situation.Cases: We describe three frail patients hospitalized for acute illness who started taking ninjin'yoeito at the time of discharge.Case 1: An 87-year-old man admitted with acute prostatitis complicated by hypertension and chronic obstructive pulmonary disease (COPD). His 36-Item Short Form Health Survey (SF-36) score, which is representative of total quality of life and comprises eight components, showed consistent improvements after 4 and 12 weeks of ninjin'yoeito administration, especially for body pain (BP; scores from 41 to 51 and 100, respectively), social function (SF; 50, 100, 100), and mental health (MH; 75, 75, 90).Case 2: A 65-year-old man admitted with urinary tract infection complicated by primary sclerosing cholangitis and COPD. All SF-36 component scores showed improvement 12 weeks later: physical function (PF; 70–95), role physical (RP; 75–100), BP (72–84), general health (GH; 45–52), vitality (VT; 37.5–75), SF 75–100, role emotional (RE; 75–100), and MH (70–90).Case 3: An 80-year-old man admitted for pneumonia complicated with hypertension. SF-36 score was improved 4 weeks later for RP (68.8–100), BP (52–61), GH (52–72), VT (43.8–62.5), SF (37.5–100), and RE (58.3–91.7).Conclusion: Patients with frailty often have a worsened SF-36 score after discharge following acute illness, but the score may be improved by taking ninjin'yoeito.

Sign in / Sign up

Export Citation Format

Share Document